Literature DB >> 1659956

Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass. Evidence for early uncoupling and late downregulation.

D A Schwinn1, B J Leone, D R Spahn, L C Chesnut, S O Page, R L McRae, S B Liggett.   

Abstract

BACKGROUND: Cardiopulmonary bypass (CPB), a process routinely used during cardiac surgery, is a potent stimulant to the release of endogenous catecholamines. Hence, we tested the hypothesis that CPB results in myocardial beta-adrenergic receptor (beta AR) desensitization. METHODS AND
RESULTS: We obtained canine transmyocardial left ventricular biopsies before, during (155 minutes), and after CPB (pre-CPB, CPB, and post-CPB, respectively) and determined beta AR density, proportion of beta 1AR to beta 2AR, and beta AR coupling capacity to adenylyl cyclase. Beta AR density was stable at 112 +/- 14 fmol/mg (pre-CPB) and 103 +/- 9 fmol/mg (CPB) but decreased post-CPB to 84 +/- 7 fmol/mg. The ratio of beta 1AR to beta 2AR (determined by two-site fit for [125I]-iodocyanopindolol competition binding with the beta 1AR selective antagonist ICI89.406) remained constant throughout (60 +/- 3: 40 +/- 3 pre-CPB, 55 +/- 3: 44 +/- 3 CPB, and 61 +/- 2: 39 +/- 2 post-CPB), revealing that both beta 1AR and beta 2AR subtypes were downregulated. A different pattern was noted in the functional properties of these receptors during CPB. Decreased maximal isoproterenol-stimulated adenylyl cyclase activity (252 +/- 14 to 216 +/- 12 pmol/30 min/mg), submaximal isoproterenol-stimulated adenylyl cyclase activity (183 +/- 10 to 157 +/- 11 pmol/30 min/mg), and zinterol-stimulated adenylyl cyclase activity (187 +/- 11 to 159 +/- 11 pmol/30 min/mg, a measure of beta 2AR subtype activation) were noted during CPB, at the time when weaning from CPB takes place. However, this desensitized pattern was found to be completely reversed by 30 minutes post-CPB, with adenylyl cyclase activities returning to pre-CPB levels or slightly higher. Control dogs that did not receive CPB showed no change in beta AR density or adenylyl cyclase activity.
CONCLUSIONS: These data suggest that myocardial beta AR desensitization does occur during CPB in healthy, nonischemic canine myocardium and that this pattern is reversed 30 minutes after discontinuation of CPB. In addition, a slower process of beta AR downregulation persists after discontinuation of CPB. Because successful weaning from CPB is a critical process during myocardial surgery, these findings have potentially important implications in the management of such patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659956     DOI: 10.1161/01.cir.84.6.2559

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Nesiritide for treatment of perioperative low cardiac output syndromes in cardiac surgical patients: an initial experience.

Authors:  George R Gordon; Roman Schumann; Hassan Rastegar; Kamal Khabbaz; Michael R England
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  Uncoupling of myocardial beta-adrenergic receptor signaling during coronary artery bypass grafting: the role of GRK2.

Authors:  Christian F Bulcao; Prakash K Pandalai; Karen M D'Souza; Walter H Merrill; Shahab A Akhter
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

3.  Bitransgenesis with beta(2)-adrenergic receptors or adenylyl cyclase fails to improve beta(1)-adrenergic receptor cardiomyopathy.

Authors:  Natalia Petrashevskaya; Brigitte R Gaume; Kathryn A Mihlbachler; Gerald W Dorn; Stephen B Liggett
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

4.  Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice.

Authors:  G W Dorn; N M Tepe; J N Lorenz; W J Koch; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.

Authors:  J Turki; J N Lorenz; S A Green; E T Donnelly; M Jacinto; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding.

Authors:  Jyoti Sharma; Nuvan Rathnayaka; Charles Green; F Gerard Moeller; Joy M Schmitz; Daniel Shoham; Anne Hamilton Dougherty
Journal:  Behav Med       Date:  2014-03-12       Impact factor: 3.104

7.  Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol.

Authors:  Kazuhiro Nakanishi; Shinhiro Takeda; Chol Kim; Shusuke Kohda; Atsuhiro Sakamoto
Journal:  J Cardiothorac Surg       Date:  2013-01-24       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.